Orchestra BioMed Holdings, Inc
Financing
Shares on issue
61.5M
From 35.8M in June 2024
a raise that quarter, at its price
Newest
$300.0M
S-3 of 2024-05-15. 2 prospectus supplements filed under it since.
$100.0M
TD Securities (USA), agreement of 2024-08-12. The amount sold under this agreement is not stated apart in the 10-Q.
Warrants
8.03M
Warrants of every class.
Cash
6.4 quarters
$101.9M cash on hand.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-11-05 | Public offering | 15,000,000 | $5.00 | $75.0M | 424B5 ↗ |
| 2026 Q3 | At-the-market sales | 1,219,499 | market | $6.2M | 10-Q ↗ |
| 2025-10-24 | Private placement | 200,000 | not available | $20.0M | 8-K ↗ |
| 2025-08-01 | Public offering incl. 5.14M pre-funded | 14,550,000 | $2.75 | $40.0M | 424B5 ↗ |
| 2025-07-31 | Private placement | not available | not available | $35.0M | 8-K ↗ |